文献速递心脑血管急症重症综合管理与镇静镇痛

转出医院门到门时间与出血性卒中结局

Door-In-Door-Out Times at Referring Hospitals and Outcomes of Hemorrhagic Stroke.
PubMed 文献 · Ann Emerg Med · 2024-10-22
一句话结论回顾性队列显示,出血性卒中患者转出ED的DIDO时间延长在未校正分析中与更好出院mRS相关,校正后关联消失,提示当前ED优先转运最重患者。

该回顾性观察性队列研究利用美国Get With The Guidelines-Stroke登记数据,纳入2019年1月1日至2022年7月31日期间从急诊转至接收医院的≥18岁脑出血(ICH)或蛛网膜下腔出血(SAH)患者。主要结局为出院改良Rankin量表(mRS)序数评分。在ICH患者中,未校正分析显示DIDO时间延长与出院mRS 0-3分(vs 4-6分)的 odds 更高相关;校正后未观察到关联。SAH患者出院mRS结果类似。作者认为当前ED在加快最重患者的转运,但需前瞻性研究和更精细数据来理解早期治疗与转运时机的影响。

要点

  • 研究纳入19708例ICH和7757例SAH患者,均为从急诊转至Get With The Guidelines参与接收医院的≥18岁患者。
  • ICH患者未校正分析:DIDO 91-180分钟 vs ≤90分钟,出院mRS 0-3分(vs 4-6分)的OR 1.15(1.04-1.27);181-270分钟 OR 1.51(1.33-1.71);>270分钟 OR 1.83(1.58-2.11)。
  • 校正分析中,ICH患者DIDO时间与出院mRS无关联;SAH患者出院mRS结果类似。
  • ICH和SAH患者中,未校正分析显示较长DIDO时间与出院独立行走 odds 更高、院内死亡 odds 更低相关;校正后效应量减小,部分基于四分位数的结果无统计学意义。
  • 作者认为这些发现提示ED目前优先转运最重患者,但需前瞻性研究和更精细数据来理解早期治疗和转运时机的影响。

适用人群与场景

  • 年龄≥18岁、诊断为脑出血(ICH)或蛛网膜下腔出血(SAH)的患者。
  • 2019年1月1日至2022年7月31日期间从急诊转至Get With The Guidelines-Stroke参与接收医院的患者。

研究设计与关键结果

  • 研究类型:回顾性观察性队列研究,使用美国Get With The Guidelines-Stroke登记数据。
  • 样本量:共纳入19708例ICH和7757例SAH患者。
  • 主要结局:出院改良Rankin量表(mRS)序数评分;次要结局包括二分类出院mRS、出院时独立行走能力和接收医院院内死亡。
  • ICH患者未校正分析:与DIDO≤90分钟相比,DIDO 91-180分钟时出院mRS 0-3分(vs 4-6分)的OR 1.15(95%CI 1.04-1.27);DIDO 181-270分钟 OR 1.51(95%CI 1.33-1.71);DIDO>270分钟 OR 1.83(95%CI 1.58-2.11)。
  • 校正分析中,未观察到DIDO时间与出院mRS的关联。
  • SAH患者出院mRS结果与ICH患者类似。
  • ICH和SAH患者中,未校正分析显示较长DIDO时间与出院独立行走 odds 更高、院内死亡 odds 更低相关;校正后效应量减小,部分基于四分位数的结果无统计学意义。

证据类型、等级与局限

  • 证据类型:回顾性观察性队列研究。
  • 局限:原文未报告局限性;作者指出需要前瞻性研究和更精细的数据来理解早期治疗和转运时机的影响。

对床旁实践的改变

  • 作者认为,这些发现提示急诊科目前正在加快最重患者的转运;但需要前瞻性研究和更精细的数据来理解早期治疗和转运时机对出血性卒中患者的影响。

指南或共识出处

  • Get With The Guidelines-Stroke登记

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Interhospital transfer is often required in the care of patients with hemorrhagic stroke. Guidelines recommend a door-in-door-out (DIDO) time of ≤120 minutes at the transferring emergency department (ED); however, it is unknown whether DIDO times are related to clinical outcomes of hemorrhagic stroke.

METHODS: Retrospective, observational cohort study using US registry data from Get With The Guidelines-Stroke participating hospitals. Patients include those aged ≥18 years with intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH) who were transferred from the ED to a Get With The Guidelines participating receiving hospital from January 1, 2019, to July 31, 2022. The primary outcome was ordinal discharge modified Rankin scale (mRS) score and secondary outcomes included dichotomous discharge mRS, ability to ambulate independently at discharge, and inhospital mortality at the receiving hospital.

RESULTS: In all, 19,708 ICH and 7,757 patients with SAH were included. For patients with ICH, an increasing DIDO time was associated with greater odds of mRS 0 to 3 versus 4 to 6 at discharge in the unadjusted analyses (DIDO 91 to 180 minutes, odds ratio [OR] 1.15 [1.04 to 1.27]; DIDO 181 to 270 minutes, OR 1.51 [1.33, 1.71]; DIDO >270 minutes, OR 1.83 [1.58, 2.11]; versus DIDO ≤90 minutes). In the adjusted analyses, no associations were observed. Similar results were seen for mRS at discharge in patients with SAH. In both patients with ICH and SAH, longer DIDO times were associated with greater odds of independent ambulation at discharge and lower odds of inhospital mortality in the unadjusted analyses. After adjustment, the effect sizes of these associations were reduced, with some of the results based on quartiles becoming statistically nonsignificant.

CONCLUSION: These findings suggest that EDs currently expedite the transfer of the sickest patients; however, prospective studies and more granular data are needed to understand the impact of early treatment and timing of transfer for patients with hemorrhagic stroke.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Royan R, Ayodele I, Stamm B, et al. Door-In-Door-Out Times at Referring Hospitals and Outcomes of Hemorrhagic Stroke. Ann Emerg Med. 2024. PMID: 39453306. doi:10.1016/j.annemergmed.2024.09.002

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。